Position in RXRX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,121,837
-$30,090 QoQ
Shares Held
691,153
+31.4% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. RXRX ranks #118 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,331,554 | $2,380,752,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,180,631 | $1,684,842,735 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,783,394 | $920,941,572 | |
| 4 | INSM |
INSMED Inc
|
4,523,921 | $739,751,561 | |
| 5 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 6 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in RXRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,121,837 | 691,153 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,151,927 | 526,144 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $2,040,643 | 418,165 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,614,705 | 319,112 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,071,387 | 202,531 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,207,463 | 178,619 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $761,479 | 115,551 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $812,002 | 108,267 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $982,682 | 98,564 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,191,934 | 120,886 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $819,237 | 107,090 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $795,628 | 106,510 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $795,162 | 119,215 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $344,019 | 44,620 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $478,288 | 44,952 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $360,463 | 44,283 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $319,571 | 44,633 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $744,691 | 43,473 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $204,838 | 5,612 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||